Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510718
Status:
COMPLETED
Last Update Posted:
2019-10-03
First Post:
2007-07-31
Brief Title:
A Phase 1 Study of MDV3100 in Patients With Castration-Resistant Hormone-Refractory Prostate Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2008-12-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-31
First Submit QC Date:
July 31 2007
Study First Post Date:
2007-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-10-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-10
Last Update Post Date:
2019-10-03
Last Update Post Date Type:
ACTUAL